Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: A cross-sectional study

Arthritis Research and Therapy

Volumn 10, Issue 6, 2008, Pages

  Toms, Tracey E ^a,b   Panoulas, Vasileios F ^a   Douglas, Karen M J ^a   Griffiths, Helen R ^c   Kitas, George D ^a,b  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; FEMALE; HUMAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LONG TERM EXPOSURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY;

AGED; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 60849113129     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2578     Document Type: Article

References (68)

1. Cobb S Anderson D Bauer W Length of life and cause of death in rheumatoid arthritis N Engl J Med 1953, 249:553-556. 13087647
2. Kitas GD Erb N Tackling ischaemic heart disease in rheumatoid arthritis Rheumatology (Oxford) 2003, 42:607-613. 10.1093/rheumatology/keg175 12709534
3. Van Doornum S McColl G Wicks IP Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002, 46:862-873. 10.1002/art.10089 11953961
4. Stevens RJ Douglas KM Saeatzis AN Kitas GD Inflammation and atherosclerosis in rheumatoid arthritis Expert Rev Mol Med 2005, 7:1-24. 10.1017/S1462399405009154 15876361
5. EMPIRE Rheumatism Council: Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results of three years' treatment Ann Rheum Dis 1957, 16:277-289. 1006963 13470729 10.1136/ard.16.3.277
6. Kirwan JR The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group N Engl J Med 1995, 333:142-146. 10.1056/ NEJM199507203330302 7791815
7. Bijlsma JW Van Everdingen AA Huisman M De Nijs RN Jacobs JW Glucocorticoids in rheumatoid arthritis: Effects on erosions and bone Ann N Y Acad Sci 2002, 966:82-90. 12114262
8. el Shaboury AH Hayes TM Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy Br Med J 1973, 2:85-86. 1589079 4349465
9. Panthakalam S Bhatnagar D Klimiuk P The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy Scott Med J 2004, 49:139-141. 15648707
10. Sarzi-Puttini P Atzeni F Schölmerich J Cutolo M Straub RH Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1(IGF1) resistence without influencing myoglobin and IGF1 binding proteins 1 and 3 Ann Rhuem Dis 2006, 65:301-305. 16079165 10.1136/ ard.2005.040816
11. Fraser R Ingram MC Anderson NH Morrison C Davies E Connell JM Cortisol effects on body mass, blood pressure, and cholesterol in the general population Hypertension 1999, 33:1364-1368. 10373217
12. Panoulas VF Douglas KM Stavropoulos-Kalinoglou A Metsios GS Nightingale P Kita MD Elisaf MS Kitas GD Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis Rheumatology (Oxford) 2008, 47:72-75. 10.1093/ rheumatology/kem311 18077493
13. Pasquali R Vicennati V Steroids and the metabolic syndrome J Steroid Biochem Mol Biol 2008, 109:258-265. 10.1016/j.jsbmb.2008.03.009 18407490
14. Rike AH Mogilishetty G Alloway RR Succop P Roy-Chaudhury P Cardi M Kaiser TE Thomas M Woodle ES Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: Comparison of early steroid withdrawal and chronic steroids Clin Transplant 2008, 22:229-235. 18339144
15. Varas-Lorenzo C Rodriguez LA Maguire A Castellsague J Perez-Gutthann S Use of oral corticosteroids and the risk of acute myocardial infarction Atherosclerosis 2007, 192:376-383. 10.1016/j.atherosclerosis.2006.05.019 16787647
16. Dessein PH Tobias M Veller MG Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis J Rheumatol 2006, 33:2425-2432. 17080519
17. Reaven GM Banting lecture 1988. Role of insulin resistance in human disease Diabetes 1988, 37:1595-1607. 10.2337/diabetes.37.12.1595 3056758
18. Reilly MP Rader DJ The metabolic syndrome: More than the sum of its parts? Circulation 2003, 108:1546-1551. 10.1161/ 01.CIR.0000088846.10655.E0 14517150
19. Sattar N McConnachie A Shaper AG Blauw GJ Buckley BM de Craen AJ Ford I Forouhi NG Freeman DJ Jukema JW Lennon L Macfarlane PW Murphy MB Packard CJ Stott DJ Westendorp RG Whincup PH Shepherd J Wannamethee SG Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies Lancet 2008, 371:1927-1935. 10.1016/S0140-6736(08)60602-9 18501419
20. Ford ES Giles WH Dietz WH Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey JAMA 2002, 287:356-359. 10.1001/jama.287.3.356 11790215
21. Ilanne-Parikka P Eriksson JG Lindström J Hämäläinen H Keinänen-Kiukaanniemi S Laakso M Louheranta A Mannelin M Rastas M Salminen V Aunola S Sundvall J Valle T Lahtela J Uusitupa M Tuomilehto J Finnish Diabetes Prevention Study Group Prevalence of the metabolic syndrome and its components: Findings from a Finnish general population sample and the Diabetes Prevention Study cohort Diabetes Care 2004, 27:2135-2140. 10.2337/diacare.27.9.2135 15333474
22. Meigs JB Wilson PW Nathan DM D'Agostino RB Sr Williams K Haffner SM Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies Diabetes 2003, 52:2160-2167. 10.2337/diabetes.52.8.2160 12882936
23. Prentice AM The emerging epidemic of obesity in developing countries Int J Epidemiol 2006, 35:93-99. 10.1093/ije/dyi272 16326822
24. Wild S Roglic G Green A Sicree R King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047 15111519
25. Kakafika AI Liberopoulos EN Karagiannis A Athyros VG Mikhailidis DP Dyslipidaemia, hypercoagulability and the metabolic syndrome Curr Vasc Pharmacol 2006, 4:175-183. 10.2174/157016106777698432 16842135
26. Tracy RP Inflammation, the metabolic syndrome and cardiovascular risk Int J Clin Pract Suppl 2003, 134:10-17. 12793593
27. Chung CP Oeser A Solus JF Avalos I Gebretsadik T Shintani A Raggi P Sokka T Pincus T Stein CM Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis Atherosclerosis 2007, 196:756-763. 10.1016/ j.atherosclerosis.2007.01.004 17266963
28. Karvounaris SA Sidiropoulos PI Papadakis JA Spanakis EK Bertsias GK Kritikos HD Ganotakis ES Boumpas DT Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: A retrospective, cross-sectional, controlled, study Ann Rheum Dis 2007, 66:28-33. 10.1136/ard.2006.053488 16793841
29. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS Medsger TA Jr Mitchell DM Neustadt DH Pinals RS Schaller JG Sharp JT Wilder RL Hunder GG The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324. 10.1002/ art.1780310302 3358796
30. Prevoo ML 't Hof MA Kuper HH van Leeuwen MA Putte van de LB van Riel PL Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107 7818570
31. Kirwan JR Reeback JS Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis Br J Rheumatol 1986, 25:206-209. 10.1093/rheumatology/25.2.206 3708236
32. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 2001, 285:2486-2497. 10.1001/jama.285.19.2486 11368702
33. Stavropoulos-Kalinoglou A Metsios GS Koutedakis Y Nevill AM Douglas KM Jamurtas A Veldhuijzen van Zanten JJ Labib M Kitas GD Redefining overweight and obesity in rheumatoid arthritis patients Ann Rheum Dis 2007, 66:1316-1321. 10.1136/ard.2006.060319 17289757
34. Alberti KG Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 1998, 15:539-553. 10.1002/ (SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693
35. Alberti KG Zimmet P Shaw J The metabolic syndrome - a new worldwide definition Lancet 2005, 366:1059-1062. 10.1016/S0140-6736(05)67402-8 16182882
36. Balkau B Charles MA Comment on the provisional report from the WHO consultation Diabetic medicine 1999, 16:442-443. 10.1046/ j.1464-5491.1999.00059.x 10342346
37. Myers J Cardiology patient pages. Exercise and cardiovascular health Circulation 2003, 107:e2-e5. 10.1161/01.CIR.0000048890.59383.8D 12515760
38. Rozman B Praprotnik S Logar D Tomsic M Hojnik M Kos-Golja M Accetto R Dolenc P Leflunomide and hypertension Ann Rheum Dis 2002, 61:567-569. 1754107 12006342 10.1136/ard.61.6.567
39. Turesson C Matteson EL et al.: Is atherosclerosis in rheumatoid arthritis related to disease severity and extraarticular manifestations? Comment on the article by Chung et al Arthritis Rheum 2006, 54:1353-1354. 10.1002/art.21777 16575863
40. Situnayake RD Kitas G Dyslipidemia and rheumatoid arthritis Ann Rheum Dis 1997, 56:341-342. 1752397 9227161 10.1136/ard.56.6.341
41. Georgiadis AN Papavasiliou EC Lourida ES Alamanos Y Kostara C Tselepis AD Drosos AA Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: Effect of early treatment - a prospective, controlled study Arthritis Res Ther 2006, 8:R82. 1526648 16646989 10.1186/ar1952
42. Wajchenberg BL Bosco A Marone MM Levin S Rocha M Lerario AC Nery M Goldman J Liberman B Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease J Clin Endocrinol Metab 1995, 80:2791-2794. 10.1210/jc.80.9.2791 7673425
43. Askari A Vignos PJ Morkavitz RW Steroid myopathy in connective tissue disease Am J Med 1976, 61:485-492. 10.1016/0002-9343(76)90327-2 973643
44. Afifi AK Bergman RA Harvey JC Steroid myopathy. Clinical, histologic and cytologic observations Johns Hopkins Med J 1968, 123:158-173. 5681186
45. Rall LC Roubenoff R Rheumatoid cachexia: Metabolic abnormalities, mechanisms and interventions Rheumatology (Oxford) 2004, 43:1219-1223. 10.1093/rheumatology/keh321 15292530
46. Roubenoff R Roubenoff RA Cannon JG Kehayias JJ Zhuang H Dawson-Hughes B Dinarello CA Rosenberg IH Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation J Clin Invest 1994, 93:2379-2386. 294444 8200971 10.1172/ JCI117244
47. Metsios GS Stavropoulos-Kalinoglou A Douglas KM Koutedakis Y Nevill AM Panoulas VF Kitas GD Blockade of TNF-alpha in rhuematoid arthritis: The effects on components of rheumatoid cachexia Rheumatology (Oxford) 2007, 46:1824-1827. 10.1093/rheumatology/kem291 18032540
48. London MG Muirden KD Hewitt JV Serum cholesterol in rheumatic diseases BMJ 1963, 25:1380-1383.
49. Svenson KL Lithell H Hallgren R Selinus I Vessby B Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity Arch Intern Med 1987, 147:1912-1916. 10.1001/archinte.147.11.1912 3675091
50. Dursunoglu D Evrengul H Polat B Tanriverdi H Cobankara V Kaftan A Kilic M Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation Rheumatol Int 2005, 25:241-245. 10.1007/s00296-004-0438-0 15290086
51. Rantapaa-Dahlqvist S Wallberg-Jonsson S Dahlen G Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis Ann Rheum Dis 1991, 50:366-368. 1004438 1829348 10.1136/ard.50.6.366
52. Boers M Nurmohamed MT Doelman CJ Lard LR Verhoeven AC Voskuyl AE Huizinga TW Stadt van de RJ Dijkmans BA Linden van der S Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis Ann Rheum Dis 2003, 62:842-845. 1754645 12922956 10.1136/ard.62.9.842
53. Choi HK Seeger JD Glucocorticoid use and serum lipid levels in US adults: The Third National Health and Nutrition Examination Survey Arthritis Rheum 2005, 53:528-535. 10.1002/art.21329 16082633
54. Ettinger WH Jr Hazzard WR Prednisolone increases very low density lipoproteins and high density lipoproteins in healthy men Metabolism 2008, 37:1055-1058. 3185288 10.1016/0026-0495(88)90067-4
55. Bocharov AV Huang W Vishniakova TG Zaitseva EV Frolova EG Rampal P Bertolotti R Glucocorticoids upregulate high-affinity, high-density lipoprotein binding sites in rat hepatocytes Metabolism 1995, 44:730-738. 10.1016/0026-0495(95)90185-X 7783657
56. Kantor MA Cullinane EM Sady SP Herbert PN Thompson PD Exercise acutely increases high density lipoprotein-cholesterol and lipoprotein lipase activity in trained and untrained men Metabolism 1987, 36:188-192. 10.1016/0026-0495(87)90016-3 3807790
57. Ettinger WH Goldberg AP Applebaum-Bowden D Hazzard WR Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids Am J Med 1987, 83:503-508. 3661587 10.1016/0002-9343(87)90762-5
58. Stern MP Kolterman OG Fries JF McDevitt HO Reaven GM Adrenocorticol steroid treatment of rheumatic diseases. Effects on lipid metabolism Arch Intern Med 1973, 132:97-101. 4541465 10.1001/archinte.132.1.97
59. Hench PS Kendall EC Slocumb CH Polley HF The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis Proc Staff Meet Mayo Clin 1949, 1949:181-197.
60. Townsend HB Saag KG Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks Clin Exp Rheumatol 2004, 22:S77-S82. 15552519
61. Panoulas VF Metsios GS Pace AC John HJ Treharne GJ Banks MJ Kitas GD Hypertension in rheumatoid arthritis Rheumatology (Oxford) 2008, 47:1286-1298. 10.1093/rheumatology/ken159 18467370
62. Hafstrom I Rohani M Deneberg S Wornert M Jogestrand T Frostegard J Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis - a randomized study J Rheumatol 2007, 34:1810-1816. 17696277
63. Han C Robinson DWJ Hackett MV Paramore LC Faeman KH Bala MV Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis J Rheumatol 2006, 33:2167-2172. 16981296
64. Skorodin MS Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies Arch Intern Med 1993, 153:814-828. 10.1001/archinte.153.7.814 8096690
65. Svenson KL Pollare T Lithell H Hallgren R Impaired glucose handling in active rheumatoid arthritis: Relationship to peripheral insulin resistance Metabolism 1988, 37:125-130. 10.1016/S0026-0495(98)90005-1 2893241
66. Dessein PH Joffe BI Stanwix AE Christian BF Veller M Glucocorticoids and insulin sensitivity in rheumatoid arthritis J Rheumatol 2004, 31:867-874. 15124244
67. Zarkovic M Beleslin B Ciric J Penezic Z Stojkovic M Trbojevic B Drezgic M Savic S Glucocorticoid effect on insulin sensitivity: A time frame J Endocrinol Invest 2008, 31:238-242. 18401206
68. Svenson KL Lundqvist G Wide L Hallgren R Impaired glucose handling in active rheumatoid arthritis: Effects of corticosteroids and antirheumatic treatment Metabolism 1987, 36:944-948. 10.1016/ 0026-0495(87)90129-6 3309546